4.7 Article

Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model

期刊

Alzheimers & Dementia
卷 12, 期 7, 页码 776-785

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2016.01.011

关键词

Alzheimer's disease; Decision analytic modelling; Progression; Prediction; Health policy

资金

  1. UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust
  2. NIA/NIH [U01 AG016976]
  3. NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P30 AG010129, P50 AG016573, P50 AG016570]
  4. [P50 AG005131]
  5. [P50 AG023501]
  6. [P30 AG035982]
  7. [P30 AG028383]
  8. [P30 AG010124]
  9. [P50 AG005133]
  10. [P50 AG005142]
  11. [P30 AG012300]
  12. [P50 AG005136]
  13. [P50 AG033514]
  14. [P50 AG005681]

向作者/读者索取更多资源

Introduction: We develop a multidomain model to predict progression of Alzheimer's disease dementia (AD). Methods: Data from the US National Alzheimer's Coordinating Center (n = 3009) are used to examine change in symptom status and to estimate transition probabilities between health states described using cognitive function, functional ability, and behavior. A model is used to predict progression and to assess a hypothetical treatment scenario that slows mild to moderate AD progression. Results: More than 70% of participants moved state over 12 months. The majority moved in domains other than cognitive function. Over 5 years, of those alive more than half are in severe AD health states. Assessing an intervention scenario, we see fewer years in more severe health states and a potential impact (life years saved) due to mortality improvements. Discussion: The model developed is exploratory and has limitations but illustrates the importance of using a multidomain approach when assessing impacts of AD and interventions. (C) 2016 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据